BLISS GVS PHARMA
Back to Income Statement
|
BLISS GVS PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹770 Cr | ₹752 Cr | ₹747 Cr | ₹577 Cr | ₹689 Cr |
What is the latest Revenue of BLISS GVS PHARMA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹770 Cr |
| Mar2024 | ₹752 Cr |
| Mar2023 | ₹747 Cr |
| Mar2022 | ₹577 Cr |
| Mar2021 | ₹689 Cr |
How is Revenue of BLISS GVS PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹770 Cr | 2.48 | |
| Mar2024 | ₹752 Cr | 0.55 | |
| Mar2023 | ₹747 Cr | 29.50 | |
| Mar2022 | ₹577 Cr | -16.26 | |
| Mar2021 | ₹689 Cr | - | |
Compare Revenue of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹3,176.1 Cr | 4.7% | 9.7% | 137.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,725.0 Cr | -3.2% | 10.5% | 9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,775.0 Cr | 0.8% | 9.5% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,764.0 Cr | 2% | 9.9% | 35.4% | Stock Analytics | |
| CIPLA | ₹113,007.0 Cr | -1.9% | 13.3% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,098.0 Cr | -1.8% | 7.4% | 8.2% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 4.7% |
9.7% |
137.8% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
You may also like the below Video Courses